Share on StockTwits

Uroplasty (NYSE:UPI) Director Kevin H. Roche purchased 10,000 shares of the stock in a transaction dated Tuesday, June 3rd. The stock was purchased at an average price of $2.97 per share, with a total value of $29,700.00. Following the acquisition, the director now directly owns 10,000 shares in the company, valued at approximately $29,700. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

Uroplasty (NYSE:UPI) opened at 2.87 on Friday. Uroplasty has a 1-year low of $1.69 and a 1-year high of $5.40. The stock has a 50-day moving average of $3.13 and a 200-day moving average of $3.46. The company’s market cap is $61.3 million.

Uroplasty (NYSE:UPI) last issued its quarterly earnings data on Thursday, May 15th. The company reported ($0.05) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.04) by $0.01. During the same quarter last year, the company posted ($0.05) earnings per share. Analysts expect that Uroplasty will post $-0.20 EPS for the current fiscal year.

Uroplasty, Inc is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.